Cholera vaccine CVD 112 - Berna Biotech

Drug Profile

Cholera vaccine CVD 112 - Berna Biotech

Alternative Names: CVD 112

Latest Information Update: 09 Jul 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Berna Biotech; Nonindustrial source
  • Developer Nonindustrial source
  • Class Cholera vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Cholera

Most Recent Events

  • 09 Jul 2002 Discontinued - Phase-I for Cholera in USA (PO)
  • 24 Jul 2001 The Swiss Serum and Vaccine Institute Berne is now called Berna Biotech
  • 19 Jul 1999 No-Development-Reported for Cholera in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top